Impact of Different Oseltamivir Regimens on Treating Influenza A Virus Infection and Resistance Emergence: Insights from a Modelling Study

Global Assessment of Resistance to Neuraminidase Inhibitors, 2008–2011: The Influenza Resistance Information Study (IRIS)

(2013) Richard J. Whitley et al.   CLINICAL INFECTIOUS DISEASES

Heterogeneity in Viral Shedding Among Individuals With Medically Attended Influenza A Virus Infection

(2013) Lincoln L. H. Lau et al.   JOURNAL OF INFECTIOUS DISEASES

Impact of Potential Permissive Neuraminidase Mutations on Viral Fitness of the H275Y Oseltamivir-Resistant Influenza A(H1N1)pdm09 Virus In Vitro, in Mice and in Ferrets

(2013) Y. Abed et al.   JOURNAL OF VIROLOGY

Optimum timing of oseltamivir: lessons from Bangladesh

(2013) Michael G Ison   LANCET INFECTIOUS DISEASES

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial

(2013) Alicia M Fry et al.   LANCET INFECTIOUS DISEASES

Stochastic Analysis of Pre- and Postexposure Prophylaxis against HIV Infection

(2013) Jessica M. Conway et al.   SIAM JOURNAL ON APPLIED MATHEMATICS

Antigenic Drift of the Pandemic 2009 A(H1N1) Influenza Virus in a Ferret Model

(2013) Teagan Guarnaccia et al.   PLoS Pathogens

Treatment With Neuraminidase Inhibitors for Critically Ill Patients With Influenza A (H1N1)pdm09

(2012) J. K. Louie et al.   CLINICAL INFECTIOUS DISEASES

Impact of Neuraminidase Inhibitor Treatment on Outcomes of Public Health Importance During the 2009-2010 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Analysis in Hospitalized Patients

(2012) S. G. Muthuri et al.   JOURNAL OF INFECTIOUS DISEASES

Systematic Identification of H274Y Compensatory Mutations in Influenza A Virus Neuraminidase by High-Throughput Screening

(2012) N. C. Wu et al.   JOURNAL OF VIROLOGY

Cluster of Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Virus Infections on a Hospital Ward among Immunocompromised Patients—North Carolina, 2009

(2011) Luke F. Chen et al.   JOURNAL OF INFECTIOUS DISEASES

Safety and Pharmacokinetics of Oseltamivir for Prophylaxis of Neonates Exposed to Influenza H1N1

(2011) Helena C. Maltezou et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Stochastic Theory of Early Viral Infection: Continuous versus Burst Production of Virions

(2011) John E. Pearson et al.   PLoS Computational Biology

Role of Permissive Neuraminidase Mutations in Influenza A/Brisbane/59/2007-like (H1N1) Viruses

(2011) Yacine Abed et al.   PLoS Pathogens

Competitive Fitness of Oseltamivir-Sensitive and -Resistant Highly Pathogenic H5N1 Influenza Viruses in a Ferret Model

(2010) E. A. Govorkova et al.   JOURNAL OF VIROLOGY

Quantifying the Early Immune Response and Adaptive Immune Response Kinetics in Mice Infected with Influenza A Virus

(2010) H. Miao et al.   JOURNAL OF VIROLOGY

Population Modeling of Influenza A/H1N1 Virus Kinetics and Symptom Dynamics

(2010) L. Canini et al.   JOURNAL OF VIROLOGY

Comparative Epidemiology of Pandemic and Seasonal Influenza A in Households

(2010) Benjamin J. Cowling et al.   NEW ENGLAND JOURNAL OF MEDICINE

Stockpiling Antiviral Drugs for the Next Influenza Pandemic

(2009) A Patel et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Towards a quantitative understanding of the within-host dynamics of influenza A infections

(2009) A. Handel et al.   Journal of the Royal Society Interface

Simulation and Prediction of the Adaptive Immune Response to Influenza A Virus Infection

(2009) H. Y. Lee et al.   JOURNAL OF VIROLOGY

Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis

(2009) Jane Burch et al.   LANCET INFECTIOUS DISEASES

Pharmacokinetics of High-Dose Oseltamivir in Healthy Volunteers

(2008) Y. Wattanagoon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008

(2008) T. G. Sheu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetics of Oseltamivir When Coadministered With Probenecid

(2008) Craig R. Rayner et al.   JOURNAL OF CLINICAL PHARMACOLOGY